7. panická porucha
7. panická porucha
7. panická porucha
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Literatura<br />
Alexander PE: Management of panic disorders. J Psychoactive Drugs 1991; 23: 329-<br />
333.<br />
Altshuler LL: Fluoxetine-associated panic attacks. J Clin Psychopharmacol 1994; 14:<br />
433-434.<br />
American Psychiatric Association: Practice guideline for the treatment of pacients<br />
with panic disorder. Am J Psychiatry 1998; 155(suppl 5): 34s.<br />
Andersch S, Rosenberg NK, Kullingsjo H et al. Efficacy and safety of alprazolam,<br />
imipramine and placebo in treating panic disorder: a Scandinavian multicenter study.<br />
Acta Psychiatr Scand 1991; 365(suppl): 18-2<strong>7.</strong><br />
Asmundson GJG a Taylor S: Anxiety disorders: Panic disorder with and without<br />
agoraphobia. In: Tasman A, Kay J, Lieberman JA (eds): Psychiatry, Second Edition,<br />
Wiley & Sons, Chichester 2003; 1281-129<strong>7.</strong>.<br />
Bakish D, Saxena BM, Bowen R, D´Souza JD: Reversible monoamine oxidaze -<br />
inhibitors in panic disorder. Clin Neuropharmacol 1993; 16 (suppl 2): S77-S82.<br />
Bakish, D., Filteau, M.J., Charbonneau, Y. et al. A double-blind, placebo-controlled<br />
trial comparing fluvoxamine and imipramine in the treatment of panic disorder with<br />
or without agoraphobia. In: Neuropsychopharmacology, pt.2, XIX th CINP, June 27-<br />
July 1, 1994, Washington, DC, Abstract 0-27-38<br />
Bakish D, Hooper CL, Filteau MJ, et al. A double blind placebo-controlled trial<br />
comparing fluvoxamine and imipramine in the treatment of panic disorder with or<br />
without agoraphobia. Psychopharmacology Bulletin 1996; 32:135-141<br />
Ballenger JC: Panic disorder in the medical setting. J Clin Psychiatry 1997; 58 (suppl<br />
2): 13-1<strong>7.</strong><br />
Ballenger, J.C.: Comorbidity of panic and depression: Implications for clinical<br />
management. International Journal of Clinical Psychopharmacology 1998; 13 (suppl<br />
4): S13-17<br />
Ballenger, J.C.: (On behalf of Paroxetine Panic Disorder Study Group), Wheadon DE,<br />
Steiner M, Bushnell W, Gergel I. Double blind, fixed dosese, placebo-controlled<br />
study of paroxetine in the treatment of panic disorder.Am J Psychiatry 1998;155: 36-<br />
42<br />
Ballenger, J.C.: Selective serotonin reuptake inhibitors (SSRIs) in panic disorder. In:<br />
D.Nutt, J. Ballenger a J.P. Lepine (eds.): Panic disorder: clinical diagnosis,<br />
management and mechanisms. Dunitz, London. 1999; 159-178<br />
Ballenger, J.C.: Panic disorder and agoraphobia. In: M.G.Gelder, J.J.Lopez-Ibor, N.<br />
Andreasen (eds.): New Oxford Textbook of Psychiatry. Oxford University Press.<br />
Oxford 2000, 807-822<br />
Ballenger, J.C., Burrows, G.D., Dupont, R.L.: Alprazolam in Panic Disorder and<br />
Agoraphobia: Results from a Multicenter Trial. Arch. Gen. Psychiatry 1988: 45: s.<br />
413-422<br />
35